Article ; Online: Imaging-guided prognostic score-based approach to assess the benefits of combotherapy versus monotherapy with immune checkpoint inhibitors in metastatic MSI-H colorectal cancer patients.
European journal of cancer (Oxford, England : 1990)
2024 Volume 202, Page(s) 114020
Abstract: ... with microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC) by analyzing quantitative imaging data and ... tumor volume, lesion count, the presence of peritoneal carcinomatosis, and age can guide MSI-H mCRC treatment ...
Abstract | Background: This retrospective study determined survival responses to immune checkpoint inhibitors (ICIs), comparing mono- (mono) and combo-immunotherapy (combo) in patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC) by analyzing quantitative imaging data and clinical factors. Methods: One hundred fifty patients were included from two centers and divided into training (n = 105) and validation (n = 45) cohorts. Radiologists manually annotated chest-abdomen-pelvis computed tomography and calculated tumor burden. Progression-free survival (PFS) was assessed, and variables were selected through Recursive Feature Elimination. Cutoff values were determined using maximally selected rank statistics to binarize features, forming a risk score with hazard ratio-derived weights. Results: In total, 2258 lesions were annotated with excellent reproducibility. Key variables in the training cohort included: total tumor volume (cutoff: 73 cm Conclusions: A score based on total tumor volume, lesion count, the presence of peritoneal carcinomatosis, and age can guide MSI-H mCRC treatment decisions, allowing oncologists to identify suitable candidates for mono and combo ICI therapies. |
---|---|
MeSH term(s) | Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Prognosis ; Colorectal Neoplasms/diagnostic imaging ; Colorectal Neoplasms/drug therapy ; Peritoneal Neoplasms/drug therapy ; Retrospective Studies ; Reproducibility of Results ; Colonic Neoplasms/drug therapy ; Microsatellite Instability ; DNA Mismatch Repair |
Chemical Substances | Immune Checkpoint Inhibitors |
Language | English |
Publishing date | 2024-03-16 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 82061-1 |
ISSN | 1879-0852 ; 0277-5379 ; 0959-8049 ; 0964-1947 |
ISSN (online) | 1879-0852 |
ISSN | 0277-5379 ; 0959-8049 ; 0964-1947 |
DOI | 10.1016/j.ejca.2024.114020 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 456: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 583: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.